ACE and renal cell carcinoma: Preclinical studies supported these data, demonstrating a “hypertrophy” of the ACE/AngII/AT1R axis in RCC tissues and proangiogenic and proinvasive effects of AT1R stimulation by AngII [9,13,14,15].